Japan· JP-3999056M1026
アバコパン
A avacopan product containing アバコパン, registered in Japan by キッセイ薬品工業, on the national reimbursement list. The same ATC class is registered in 13 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Avacopan is registered in 13 of 19 countries.
Countries holding a registration under ATC L04AJ05 (avacopan), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 7 of them publish a price we can compare per daily dose
Avacopan · ATC L04AJ05
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of avacopan costs, country by country.
Normalised to the WHO defined daily dose (60 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Avacopan · price per daily dose (60 mg)
USD · FX 28 Sept 2026
- CH Switzerland$232.12
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- アバコパン
- Manufacturer
- キッセイ薬品工業
- Country
- Japan (JP)
- ATC code
- L04AJ05
- ATC class
- Avacopan
- Defined daily dose
- 60 mg, O
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under L04AJ05
Avacopan, as other registers publish it.
- FinlandTavneosVifor Fresenius Medical Care Renal Pharma France
- DenmarkTavneosVifor Fresenius Medical Care Renal Pharma France
- IcelandTavneosVifor Fresenius Medical Care Renal Pharma France*
- NorwayTavneosVifor Fresenius Medical Care Renal Pharma France
- CzechiaTAVNEOSVifor Fresenius Medical Care Renal Pharma France, Paříž
- CzechiaTAVNEOSVifor Fresenius Medical Care Renal Pharma France, Paříž
- CzechiaTAVNEOSVifor Fresenius Medical Care Renal Pharma France, Paříž
- United StatesTAVNEOSChemoCentryx, Inc.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ef1d4cb1-0acc-4a41-8b87-c44026578040 GET /v1/drugs/ef1d4cb1-0acc-4a41-8b87-c44026578040?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "10mg1カプセル",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "3999056M1026",
"category": "内用薬",
"price_yen": 1403.9,
"generic_name": "アバコパン",
"product_name_jp": null,
"therapeutic_class": "3999",
"transitional_expiry": null
}See everything about avacopan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.